Family Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.04M Buy
865
+60
+7% +$61.3K 0.4% 46
2026
Q1
$740K Buy
805
+91
+13% +$92.3K 0.33% 55
2025
Q4
$767K Buy
714
+104
+17% +$99.4K 0.34% 52
2025
Q3
$465K Buy
610
+143
+31% +$106K 0.22% 63
2025
Q2
$364K Buy
467
+212
+83% +$165K 0.19% 69
2025
Q1
$211K Buy
+255
New +$212K 0.13% 71

Other funds holding LLY

Family Capital Management's LLY Position: Q2 2026 in Review

Family Capital Management increased its Eli Lilly (LLY) stake by 7.5% in Q2 2026, buying an estimated $61.3K and bringing the position to 865 shares worth $1.04M. The position accounts for 0.4% of the portfolio, ranked #46.

Family Capital Management first reported a position in LLY in Q1 2025 and has held it in 6 quarters since. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Family Capital Management held 865 shares of Eli Lilly worth $1.04M as of Q2 2026.
  • Family Capital Management bought 60 Eli Lilly shares in Q2 2026, an estimated $61.3K.
  • Eli Lilly made up 0.4% of Family Capital Management's portfolio in Q2 2026, its #46 holding.
  • Family Capital Management first reported a position in Eli Lilly in Q1 2025 and has held it in 6 quarters since.
  • 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Family Capital Management's 13F filing for Q2 2026, filed 31 Jul 2026.